Literature DB >> 10532496

Restructuring asthma care in a hospital setting to improve outcomes.

R Evans1, S LeBailly, K K Gordon, A Sawyer, K K Christoffel, B Pearce.   

Abstract

STUDY
OBJECTIVES: To restructure asthma care as the pilot program in hospital-wide redesign aimed at providing better and more standardized care. We chose asthma care to begin our reorganization because it is the highest-volume diagnosis at our hospital and it involves a broad spectrum of services.
DESIGN: Key elements of our restructuring included the following: (1) establishing a pulmonary unit with expanded bed capacity from 8 to 22 beds for asthma patients; (2) standardized treatment protocols; (3) availability of direct admission by primary care physicians who maintained management of their patients with the option of consultation with a specialist; and (4) use of case managers who helped patients and their families overcome obstacles to optimum care.
SETTING: A hospital serving a high proportion of Medicaid patients. PATIENTS/PARTICIPANTS: Children with asthma and their families.
INTERVENTIONS: Standardized care for asthma; use of case managers to facilitate adherence to treatment.
RESULTS: With the restructured asthma care program, parent satisfaction with treatment was sustained; the average length of stay and use of the emergency department (ED) were reduced; observation unit use increased; and there were fewer readmissions to both the inpatient unit and the ED.
CONCLUSIONS: We conclude that an inner-city hospital can provide optimum care for asthma patients by standardizing treatment, aggregating asthma patients in one location, and providing education and follow-up through the use of case managers. The protocol shifts some costs from expensive services such as the pediatric ICU and the ED to less costly case management and outreach personnel. In the long run, this allocation of resources should help to lower costs as well as improve quality of care.

Entities:  

Mesh:

Year:  1999        PMID: 10532496     DOI: 10.1378/chest.116.suppl_2.210s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Shared care--is it worth it for the patient?

Authors:  Iolo Doull
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Implementation of an in-patient pediatric mortality reduction intervention, Gondar University Hospital, Ethiopia.

Authors:  D M Gordon; A Shehibo; A Tazebew; M R Huddart; A Kadir; N Allen; H Draper; M Kokeb
Journal:  Public Health Action       Date:  2014-12-21

3.  Tailored education may reduce health literacy disparities in asthma self-management.

Authors:  Michael K Paasche-Orlow; Kristin A Riekert; Andrew Bilderback; Arjun Chanmugam; Peter Hill; Cynthia S Rand; Fred L Brancati; Jerry A Krishnan
Journal:  Am J Respir Crit Care Med       Date:  2005-08-04       Impact factor: 21.405

4.  Care models and associated outcomes in congenital heart surgery.

Authors:  Danielle S Burstein; Jeffrey P Jacobs; Jennifer S Li; Shubin Sheng; Sean M O'Brien; Anthony F Rossi; Paul A Checchia; Gil Wernovsky; Karl F Welke; Eric D Peterson; Marshall L Jacobs; Sara K Pasquali
Journal:  Pediatrics       Date:  2011-05-16       Impact factor: 7.124

5.  An Iterative Quality Improvement Process Improves Pediatric Ward Discharge Efficiency.

Authors:  Michelle Y Hamline; Lori Rutman; Daniel J Tancredi; Jennifer L Rosenthal
Journal:  Hosp Pediatr       Date:  2020-02-12

6.  Hospital-to-Home Interventions, Use, and Satisfaction: A Meta-analysis.

Authors:  Michelle Y Hamline; Rebecca L Speier; Paul Dai Vu; Daniel Tancredi; Alia R Broman; Lisa N Rasmussen; Brian P Tullius; Ulfat Shaikh; Su-Ting T Li
Journal:  Pediatrics       Date:  2018-10-23       Impact factor: 7.124

7.  Utilization of mechanical ventilation for asthma exacerbations: analysis of a national database.

Authors:  Rahul Nanchal; Gagan Kumar; Tillotama Majumdar; Amit Taneja; Jayshil Patel; Gaurav Dagar; Elizabeth R Jacobs; Jeff Whittle
Journal:  Respir Care       Date:  2013-10-08       Impact factor: 2.258

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.